Ex vivo chemosensitivity testing and gene expression profiling predict response towards adjuvant gemcitabine treatment in pancreatic cancer

por Michalski, C W, Erkan, M, Sauliunaite, D, Giese, T, Stratmann, R, Sartori, C, Giese, N A, Friess, H, Kleeff, J
Publicado 2008